郑重说明:

您值得信赖的中药成分及标准合作伙伴满足您研发和工业化需求

产品关键词：香草酸-4-β-D-葡萄糖苷 6-甲氧基山奈酚茯苓新酸B 去甲异波尔定

guanyuwomen关于德思特

联系方式

服务热线：

028-8500-3950

公司传真：	028-85589956
公司邮箱：	sales@tcmlmt.com
公司网址：	www.028desite.com
公司地址：	四川省成都市温江区海科路西段128号5栋

发表文献展示

当前位置:首页关于德思特 > 发表文献展示 >

Phytomedicine-14 May 2020 香蒲新苷 α-亚麻酸紫云英苷柚皮素

时间：2020-09-03 浏览次数：分享到：

Thrombin-based discovery strategy of bioactive-chemical quality marker combination for pollen of Typha orientalis by metabolomics coupled with chemometrics

期刊名：Phytomedicine
文献编号：DOI 10.1016/j.phymed.2020.153246
文献地址：https://www.sciencedirect.com/science/article/abs/pii/S0944711320300775?via%3Dihub
发表日期：14 May 2020

Abstract
Background
It is of utmost significance to choose the bioactive components as quality markers for ensuring the effectiveness of traditional Chinese medicine. Nonetheless, some markers are able to assess effectively the quality of TCM without considering the pharmacological mechanisms and intrinsic chemical complexities.

Objective
This underscores the need to discover new and efficient markers which can assess both quality and mechanism of action. Herein, a strategy of bioactive-chemical quality markers combination was proposed to improve the level of the quality control of TCM by metabolomics coupled with chemometrics.

Reference standards of typhaneoside, kaempferol-3-O-neohesperidoside, citric acid, linolenic acid, kaempferol-3-O-neohesperidoside, astragalin, naringenin, puerarin, and succinic acid with 98% purity on the basis of HPLC analysis were supplied by Chengdu Desite Biological Technology Co. Ltd. (Sichuan, China)

上一篇：Molecules-20 January 2020 白杨素芹菜素香叶木素山奈酚-7-O-葡萄

下一篇：Biochemical Pharmacology-13 May 2020 黄芩素